Showing 181 - 200 results of 3,464 for search '"Hiroshima"', query time: 0.11s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184
  5. 185
  6. 186
  7. 187
  8. 188

    Utility of Covered Self-Expanding Metal Stents for Biliary Drainage during Neoadjuvant Chemotherapy in Patients with Borderline Resectable Pancreatic Cancer by Masaru Furukawa, Yasutaka Ishii, Masahiro Serikawa, Tomofumi Tsuboi, Yumiko Tatsukawa, Tetsuro Hirano, Shinya Nakamura, Juri Ikemoto, Yusuke Kiyoshita, Sho Saeki, Yosuke Tamura, Sayaka Miyamoto, Kazuki Nakamura, Yumiko Yamashita, Noriaki Iijima, Kenichiro Uemura, Shiro Oka

    Published 2023-09-01
    “…Methods: Forty patients with borderline resectable pancreatic cancer underwent biliary stenting during neoadjuvant chemotherapy at Hiroshima University Hospital. PSs and CSEMSs were placed in 19 and 21 patients, respectively. …”
    Get full text
    Article
  9. 189

    Efficacy and safety of lenvatinib–transcatheter arterial chemoembolisation sequential therapy followed by surgical resection for intermediate-stage hepatocellular carcinoma beyond... by Hiroshi Aikata, Hiroshi Sakai, Michio Imamura, Masahiro Ohira, Tsuyoshi Kobayashi, Ryosuke Nakano, Naoki Tanimine, Shintaro Kuroda, Hiroyuki Tahara, Kentaro Ide, Hideki Ohdan, Ko Oshita, Yosuke Namba, Sotaro Fukuhara, Keiso Matsubara, Daisuke Takei, Wataru Okamoto, Takashi Nakahara, Tomokazu Kawaoka

    Published 2023-10-01
    “…The secondary outcomes are the objective response rate of LEN–TACE sequential therapy, safety, curative resection rate, overall survival and recurrence-free survival.Ethics and dissemination This trial was approved by the Institutional Review Board of Hiroshima University, Japan (approval no. CRB210003), and has been registered with the Japan Registry of Clinical Trials (jRCTs061220007). …”
    Get full text
    Article
  10. 190
  11. 191
  12. 192
  13. 193
  14. 194
  15. 195
  16. 196
  17. 197
  18. 198
  19. 199
  20. 200